# Mammogram Pretreatment With Ulipristal Acetate

> **NCT07434128** · PHASE2 · NOT_YET_RECRUITING · sponsor: **OHSU Knight Cancer Institute** · enrollment: 26 (estimated)

## Conditions studied

- Mammography Screening
- Breast Density

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Magnetic Resonance Imaging
- **PROCEDURE:** Mammogram
- **OTHER:** Survey Administration
- **DRUG:** Ulipristal Acetate

## Key facts

- **NCT ID:** NCT07434128
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-02
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2026-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07434128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07434128, "Mammogram Pretreatment With Ulipristal Acetate". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07434128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*